Cargando…
Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
The use and interpretation of diagnostic cerebrospinal fluid (CSF) biomarkers for neurodegenerative disorders, such as Dementia with Lewy bodies (DLB), represent a clinical challenge. According to the literature, the composition of CSF in DLB patients varies. Some patients present with reduced level...
Autores principales: | Foska, Aikaterini, Tsantzali, Ioanna, Sideri, Eleni, Stefanou, Maria Ioanna, Bakola, Eleni, Kitsos, Dimitrios K., Zompola, Christina, Bonakis, Anastasios, Giannopoulos, Sotirios, Voumvourakis, Konstantinos I., Tsivgoulis, Georgios, Paraskevas, George P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144333/ https://www.ncbi.nlm.nih.gov/pubmed/35630029 http://dx.doi.org/10.3390/medicina58050612 |
Ejemplares similares
-
Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer’s Disease
por: Tsantzali, Ioanna, et al.
Publicado: (2022) -
The Dynamic Relationship between the Glymphatic System, Aging, Memory, and Sleep
por: Voumvourakis, Konstantinos I., et al.
Publicado: (2023) -
From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients
por: Tsantzali, Ioanna, et al.
Publicado: (2021) -
Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders
por: Tzartos, John S., et al.
Publicado: (2022) -
Guillain-Barré syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy
por: Stefanou, Maria Ioanna, et al.
Publicado: (2022)